Aktuellt
SENASTE
Redeye briefly comments on Scandion announcing CORIST’s expansion to recruit patients in Germany and Spain. The company has previously noted its intention to internationalize its trials, and thus today’s announcement aligns with our expectations. We reiterate our positive view of Scandion, with important clinical data from CORIST and PANTAX coming up in Q2 to Q3 of this year.
LÄS MER
